Clinical Trial

Medication Adherence and Lipid Management in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention: Application of the Transitional Care Model

Completed
View on ClinicalTrials.gov →
Summary
Patients with coronary heart disease (CHD) require long-term medication and lifestyle modification following percutaneous coronary intervention (PCI). However, they often face challenges such as poor medication adherence and inadequate self-management. This study aims to evaluate the effects of the transitional care model (TCM) on CHD patients after PCI, regarding medication adherence, self-efficacy, and lipid levels.
Trial Details
NCT Number NCT07346664
Lead Sponsor Qing Wang
Conditions Transitional Care Model, Coronary Heart Disease, Medication Adherence, Self-efficacy, Lipid Profile
Enrollment 108 participants
Start Date 2022-07-11
Primary Completion 2024-05-09 (estimated)
Study Completion 2024-05-26 (estimated)
Updated on ClinicalTrials.gov 2026-01-16